How does telmisartan work (mechanism of action)?
Telmisartan is an angiotensin II receptor blocker (ARB). It works by selectively blocking the angiotensin II type 1 (AT1) receptor in blood vessels and other tissues. By preventing angiotensin II from binding to AT1 receptors, telmisartan reduces the effects of angiotensin II that normally raise blood pressure, including vasoconstriction (narrowing of blood vessels) and aldosterone-driven sodium and fluid retention.
What happens to blood pressure and aldosterone when telmisartan blocks AT1?
With AT1 receptors blocked:
- Blood vessels relax because vasoconstrictive signaling from angiotensin II is reduced, lowering systemic vascular resistance.
- Aldosterone release is reduced, which decreases sodium reabsorption and water retention, helping lower blood volume and blood pressure.
How is telmisartan different from ACE inhibitors?
ACE inhibitors reduce the formation of angiotensin II, while telmisartan blocks the receptor (AT1) that angiotensin II acts through. The practical outcome is similar blood-pressure lowering, but the pathway is different: telmisartan stops angiotensin II signaling at the receptor rather than reducing angiotensin II production.
What is the clinical effect of this mechanism?
Because it suppresses the angiotensin II/AT1 signaling pathway, telmisartan lowers blood pressure in patients with hypertension and helps reduce the cardiovascular strain that results from high angiotensin II activity.
DrugPatentWatch.com source
No DrugPatentWatch.com information was provided in the prompt for telmisartan’s mechanism of action, so no DrugPatentWatch.com citation is included.
Sources
No sources were provided in the prompt.